Gene therapy vectors and cytosine deaminases

Details for Australian Patent Application No. 2009303690 (hide)

Owner Tocagen Inc.

Inventors Gruber, Harry E.; Jolly, Douglas; Perez, Omar; Logg, Christopher, R.

Agent Cullens

Pub. Number AU-A-2009303690

PCT Pub. Number WO2010/045002

Priority 61/120,618 08.12.08 US; 61/100,666 26.09.08 US; 61/186,823 13.06.09 US

Filing date 26 September 2009

Wipo publication date 22 April 2010

International Classifications

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/52 (2006.01) Mutation or genetic engineering - Genes encoding for enzymes or proenzymes

C12N 15/867 (2006.01) Mutation or genetic engineering - Retroviral vectors

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/045002 Priority application(s): WO2010/045002

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009303692-Post certification metering for diverse game machines

2009303683-Systems and methods for predilution of sweetener